Bottom line
SLYG vs RZG: the short answer
SLYG (State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF) and RZG (Invesco S&P SmallCap 600 Pure Growth ETF) are quite different portfolios: only about 15% of their top holdings (by weight) are shared.
But SLYG is far broader, holding 351 positions to 131 for RZG, so beyond the top names it adds exposure RZG doesn't have.
SLYG is cheaper at 0.15% vs 0.35% — a difference of $20 a year per $10,000 invested.
Over five years, SLYG returned +5.4% a year vs +4.4% for RZG.
Updated Nov 19, 2026
SLYG vs RZG side by side
| SLYG | RZG | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | Invesco |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.15% | 0.35% |
| Annual cost per $10k | $15 | $35 |
| 10-yr cost on $10k (prospectus) | $192 | $444 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +5.2% | +10.2% |
| 5-yr return (annualized) | +5.4% | +4.4% |
| 10-yr return (annualized) | +9.7% | +8.1% |
| Best quarter | +29.8% | +31.7% |
| Worst quarter | −28.1% | −35.2% |
| Net assets (fund) | $5.2B | $137.8M |
| Number of holdings | 351 | 131 |
| Portfolio turnover | 53% | 81% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SLYG | RZG | Difference |
|---|---|---|---|
| 2025 | +5.2% | +10.2% | −5.0% |
| 2024 | +9.5% | +9.8% | −0.4% |
| 2023 | +17.0% | +19.1% | −2.1% |
| 2022 | −21.2% | −29.0% | +7.8% |
| 2021 | +22.4% | +21.0% | +1.5% |
| 2020 | +19.4% | +17.6% | +1.8% |
| 2019 | +20.9% | +14.3% | +6.7% |
| 2018 | −4.1% | −7.7% | +3.6% |
| 2017 | +14.6% | +17.9% | −3.3% |
| 2016 | +22.1% | +20.6% | +1.5% |
Source: Fund prospectus bar charts
Holdings overlap
6 of SLYG's top 25 holdings also appear in RZG's top 25.
| Holding | SLYG | RZG |
|---|---|---|
| Argan Inc | 1.22% | 1.46% |
| StoneX Group Inc | 0.92% | 1.62% |
| Corcept Therapeutics Inc | 0.91% | 1.27% |
| Powell Industries Inc | 0.89% | 1.50% |
| Protagonist Therapeutics Inc | 0.81% | 1.78% |
| ACM Research Inc | 0.79% | 2.36% |
Source: SEC Form N-PORT
SLYG top 10
- State Street Global Advisors — 2.54%
- FormFactor Inc — 1.37%
- Viasat Inc — 1.34%
- Argan Inc — 1.22%
- BrightSpring Health Services Inc — 1.21%
- Krystal Biotech Inc — 1.07%
- ESCO Technologies Inc — 0.99%
- Alkermes PLC — 0.95%
- Everus Construction Group Inc — 0.93%
- StoneX Group Inc — 0.92%
RZG top 10
- Invesco Private Prime Fund — 21.55%
- Invesco Private Government Fund — 8.30%
- ACM Research, Inc. — 2.36%
- Dave Inc. — 1.87%
- Protagonist Therapeutics, Inc. — 1.78%
- Acadian Asset Management Inc. — 1.68%
- Chefs' Warehouse, Inc. (The) — 1.64%
- StoneX Group Inc. — 1.62%
- Liquidia Corp. — 1.60%
- Enova International, Inc. — 1.57%
FAQ
What is the difference between SLYG and RZG?
Which is cheaper, SLYG or RZG?
Should I own both SLYG and RZG?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.